Synlett 2016; 27(07): 1091-1095
DOI: 10.1055/s-0035-1561317
letter
© Georg Thieme Verlag Stuttgart · New York

Palladium-Catalyzed Direct Arylation of 2,6-Disubstituted Imidazo[2,1-b][1,3,4]thiadiazoles

Chloé Copin
Institut de Chimie Organique et Analytique, ICOA, Univ Orleans, UMR 7311 CNRS, Rue de Chartres, BP 6759, 45067 Orleans, France   Email: sylvain.routier@univ-orleans.fr
,
Nicolas Henry
Institut de Chimie Organique et Analytique, ICOA, Univ Orleans, UMR 7311 CNRS, Rue de Chartres, BP 6759, 45067 Orleans, France   Email: sylvain.routier@univ-orleans.fr
,
Frédéric Buron
Institut de Chimie Organique et Analytique, ICOA, Univ Orleans, UMR 7311 CNRS, Rue de Chartres, BP 6759, 45067 Orleans, France   Email: sylvain.routier@univ-orleans.fr
,
Sylvain Routier*
Institut de Chimie Organique et Analytique, ICOA, Univ Orleans, UMR 7311 CNRS, Rue de Chartres, BP 6759, 45067 Orleans, France   Email: sylvain.routier@univ-orleans.fr
› Author Affiliations
Further Information

Publication History

Received: 18 November 2015

Accepted after revision: 14 December 2015

Publication Date:
08 January 2016 (online)


Abstract

This work reports the original synthesis of trisarylimidazo[2,1-b][1,3,4]thiadiazole derivatives using a C–H arylation process. The scope of the reaction demonstrated the critical importance of the electronic effects of each substituent on the efficiency of the reaction. In addition, a double efficient ‘one-pot’ functionalization at the C-2 and then at the C-5 positions of 2-bromo-6-arylimidazo[2,1-b][1,3,4]thiadiazole derivatives was achieved using a sequential Suzuki–Miyaura–C–H arylation cascade procedure.

Supporting Information

 
  • References and Notes

  • 4 Routier S, Peixoto P, Mérour J.-Y, Coudert G, Dias N, Bailly C, Pierré A, Léonce S, Caignard D.-H. J. Med. Chem. 2005; 48: 1401
    • 5a Le Meur M, Bourg S, Massip S, Marchivie M, Jarry C, Guillaumet G, Routier S. Eur. J. Org. Chem. 2014; 3704
    • 5b Othman RB, Massip S, Marchivie M, Jarry C, Vercouillie J, Chalon S, Guillaumet G, Suzenet F, Routier S. Eur. J. Org. Chem. 2014; 3225
  • 7 Terzioglu N, Gürsoy A. Eur. J. Med. Chem. 2003; 38: 781
  • 8 Kolavi G, Hegde V, Khazi IA, Gadad P. Bioorg. Med. Chem. 2006; 14: 3069
  • 9 Gadad AK, Palkar MB, Anand K, Noolvi MN, Boreddy TS, Wagwade J. Bioorg. Med. Chem. 2008; 16: 276
  • 10 Copin C, Henry N, Buron F, Routier S. Eur. J. Org. Chem. 2012; 6804
    • 12a Simmons EM, Hartwig JF. Angew. Chem. Int. Ed. 2012; 51: 3066
    • 12b Le Meur M, Bourg S, Massip S, Marchivie M, Jarry C, Guillaumet G, Routier S. Eur. J. Org. Chem. 2014; 3704
  • 13 General Procedure A solution of 2,6-disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivative (1.0 equiv), Cs2CO3 (3.0 equiv) and (het)aryl bromide (1.5 equiv) in dry 1,4-dioxane or toluene (3 mL for 80 mg) was degassed by argon bubbling for 15 min. Xantphos (0.2 equiv) and Pd(OAc)2 (0.1 equiv) were then added, and the mixture was heated to 150 °C for 60 min under microwave irradiation. After removing the solvent in vacuo, the crude product was purified by flash chromatography on silica gel.
  • 14 2-(4-Methylphenyl)-5-phenyl-6-(4-nitrophenyl)imidazo-[2,1-b][1,3,4]thiadiazole (2) The reaction was carried out as described in general procedure using 1 (80 mg, 0.24 mmol, 1.0 equiv) and bromobenzene (37 μL, 0.36 mmol, 1.5 equiv) in dioxane (3 mL). The crude product was purified by flash chromatography on silica gel (PE–CH2Cl2, 2:8 to 0:1) to afford 2 as a yellow solid (90 mg, 91%). Rf = 0.36 (PE–CH2Cl2, 2:8); mp >260 °C. IR (ATR diamond): ν = 1593, 1505, 1481, 1338, 1324, 1108, 1084, 971, 856, 816, 739, 708, 681 cm–1. 1H NMR (400 MHz, CDCl3): δ = 8.16 (d, J = 8.7 Hz, 2 H, 2 × HAr), 7.83 (d, J = 8.7 Hz, 2 H, 2 × HAr), 7.77 (d, J = 8.1 Hz, 2 H, 2 × HAr), 7.65 (dd, J = 7.6, 1.5 Hz, 2 H, 2 × HAr), 7.56–7.44 (m, 3 H, 3 × HAr), 7.30 (d, J = 8.1 Hz, 2 H, 2 × HAr), 2.46 (s, 3 H, CH3) ppm. 13C NMR (101 MHz, CDCl3): δ = 162.6 (Cq), 146.8 (Cq), 145.3 (Cq), 142.8 (Cq), 141.4 (Cq), 140.0 (Cq), 130.1 (2 × CHAr), 129.6 (2 × CHAr), 129.3 (CHAr), 129.2 (2 × CHAr), 128.5 (Cq), 128.0 (2 × CHAr), 127.5 (Cq), 127.0 (2 × CHAr), 126.0 (Cq), 124.0 (2 × CHAr), 21.8 (CH3) ppm. HRMS (EI-MS): m/z calcd for C23H16N4O2S: 413.10667 [M + H]+; found: 413.10692.